Closing the HPV Testing Gap Act
Key claim: The Closing the HPV Testing Gap Act (HR8939, 119th Congress) would address gaps in HPV testing access and has been referred to the House Committee on Energy and Commerce.
Abstract
(HR8939 · 119th Congress) Latest action (2026-05-20): Referred to the House Committee on Energy and Commerce.
Why this matters
HPV testing is a core cervical cancer screening pathway, and federal legislation targeting access/coverage gaps could change what patients pay and which populations reliably receive screening. As an introduced bill referred to House Energy and Commerce, HR8939 is at an early stage with no immediate effect on coverage, but it signals congressional attention to preventive screening equity.